NICE approve skin cancer drugs
Two life-extending drugs used to treat the most dangerous form of skin cancer have been given the go-ahead for use on the NHS.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
- Customised email alerts straight to your inbox (30+ alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units